Aramco’s VC arm leads $35m round of Hong Kong biotech firm

// Insilico Medicine, a Hong Kong-based biotechnology firm, has raised US$35 million in a series D2 funding round led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures. The round also saw participation from Warburg Pincus, B Capital Group, and Qiming Venture Partners. https://www.techinasia.com/insilico-medicine-series-d2-funding-aramco //

迴響已關閉。

在 WordPress.com 建立網站或網誌

向上 ↑

%d 位部落客按了讚: